advertisement
Japanese Journal of Ophthalmology 17
Showing records 1 to 17 |
Display all abstracts in Japanese Journal of Ophthalmology112512 Additive effects of brimonidine tartrate 0.1%/brinzolamide 1% fixed-dose combination in prostaglandin analog-treated Japanese glaucoma patientsSakata R
Japanese Journal of Ophthalmology 2023; 67: 668-677
112507 Lens factor as an underlying mechanism in primary angle closure with gonioscopically-visualized ciliary body processesTekcan H
Japanese Journal of Ophthalmology 2023; 67: 678-684
111879 Prediction of visual field progression in glaucoma: existing methods and artificial intelligenceAsaoka R
Japanese Journal of Ophthalmology 2023; 67: 546-559
112379 Persistence of the carteolol hydrochloride/latanoprost fixed-combination ophthalmic solution, compared with the other β-blocker/prostanoid FP receptor agonist fixed-combination ophthalmic solutionsKashiwagi K
Japanese Journal of Ophthalmology 2023; 67: 658-667
112283 Surgical safety and efficacy of a multi-stent system, the comet stent, in Baerveldt glaucoma implant surgery: a prospective pilot studyManabe SI; Hirata A
Japanese Journal of Ophthalmology 2023; 67: 685-692
112379 Persistence of the carteolol hydrochloride/latanoprost fixed-combination ophthalmic solution, compared with the other β-blocker/prostanoid FP receptor agonist fixed-combination ophthalmic solutionsOuchi K
Japanese Journal of Ophthalmology 2023; 67: 658-667
112512 Additive effects of brimonidine tartrate 0.1%/brinzolamide 1% fixed-dose combination in prostaglandin analog-treated Japanese glaucoma patientsMizoue S
Japanese Journal of Ophthalmology 2023; 67: 668-677
112507 Lens factor as an underlying mechanism in primary angle closure with gonioscopically-visualized ciliary body processesMangan MS
Japanese Journal of Ophthalmology 2023; 67: 678-684
111879 Prediction of visual field progression in glaucoma: existing methods and artificial intelligenceMurata H
Japanese Journal of Ophthalmology 2023; 67: 546-559
112507 Lens factor as an underlying mechanism in primary angle closure with gonioscopically-visualized ciliary body processesCelik G
Japanese Journal of Ophthalmology 2023; 67: 678-684
112283 Surgical safety and efficacy of a multi-stent system, the comet stent, in Baerveldt glaucoma implant surgery: a prospective pilot studyAkagi T
Japanese Journal of Ophthalmology 2023; 67: 685-692
112379 Persistence of the carteolol hydrochloride/latanoprost fixed-combination ophthalmic solution, compared with the other β-blocker/prostanoid FP receptor agonist fixed-combination ophthalmic solutionsShibasaki Y
Japanese Journal of Ophthalmology 2023; 67: 658-667
112512 Additive effects of brimonidine tartrate 0.1%/brinzolamide 1% fixed-dose combination in prostaglandin analog-treated Japanese glaucoma patientsYoshikawa K
Japanese Journal of Ophthalmology 2023; 67: 668-677
112283 Surgical safety and efficacy of a multi-stent system, the comet stent, in Baerveldt glaucoma implant surgery: a prospective pilot studyHayashi K
Japanese Journal of Ophthalmology 2023; 67: 685-692
112379 Persistence of the carteolol hydrochloride/latanoprost fixed-combination ophthalmic solution, compared with the other β-blocker/prostanoid FP receptor agonist fixed-combination ophthalmic solutionsSuginaka M
Japanese Journal of Ophthalmology 2023; 67: 658-667
112507 Lens factor as an underlying mechanism in primary angle closure with gonioscopically-visualized ciliary body processesImamoglu S
Japanese Journal of Ophthalmology 2023; 67: 678-684
112512 Additive effects of brimonidine tartrate 0.1%/brinzolamide 1% fixed-dose combination in prostaglandin analog-treated Japanese glaucoma patientsAdachi M; Ohkubo S; Hamada N; Naito T; Muramatsu T; Hara T; Asato R; Aihara M
Japanese Journal of Ophthalmology 2023; 67: 668-677